Amy Bachrodt

Companies

• Maze Therapeutics, Inc.SVP, Finance Jan 30, 2025 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• MTMaze Therapeutics, Inc. MAZE12,965 shares²$356.3K at $27.48Apr 1, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Apr 1, 2026Sold 300 shares at $30.34 of Maze Therapeutics, Inc.²
• Apr 1, 2026Sold 2,200 shares at $29.32 of Maze Therapeutics, Inc.²
• Apr 1, 2026Exercised options 2,500 shares at $10.42 of Maze Therapeutics, Inc.²
• Mar 2, 2026Sold 3,700 shares at $45.47 of Maze Therapeutics, Inc.³
• Mar 2, 2026Sold 1,300 shares at $44.44 of Maze Therapeutics, Inc.³
• Mar 2, 2026Exercised options 5,000 shares at $10.42 of Maze Therapeutics, Inc.³
• Feb 2, 2026Sold 736 shares at $46.63 of Maze Therapeutics, Inc.⁴
• Feb 2, 2026Sold 4,064 shares at $46.03 of Maze Therapeutics, Inc.⁴
• Feb 2, 2026Sold 200 shares at $44.15 of Maze Therapeutics, Inc.⁴
• Feb 2, 2026Exercised options 156 shares at $10.42 of Maze Therapeutics, Inc.⁴
• Feb 2, 2026Exercised options 4,844 shares at $10.42 of Maze Therapeutics, Inc.⁴
• Jan 22, 2026Sold 5,000 shares at $45.52 of Maze Therapeutics, Inc.⁵
• Jan 22, 2026Exercised options 2,503 shares at $10.42 of Maze Therapeutics, Inc.⁵
• Jan 22, 2026Exercised options 2,497 shares at $10.42 of Maze Therapeutics, Inc.⁵
• Jan 2, 2026Sold 2,595 shares at $39.57 of Maze Therapeutics, Inc.⁶
• Jan 2, 2026Sold 2,405 shares at $38.70 of Maze Therapeutics, Inc.⁶
• Jan 2, 2026Exercised options 4,796 shares at $10.42 of Maze Therapeutics, Inc.⁶
• Jan 2, 2026Exercised options 204 shares at $10.42 of Maze Therapeutics, Inc.⁶
• Dec 30, 2025Sold 5,000 shares at $40.08 of Maze Therapeutics, Inc.⁷
• Dec 30, 2025Exercised options 2,605 shares at $10.42 of Maze Therapeutics, Inc.⁷
• Dec 30, 2025Exercised options 2,395 shares at $10.42 of Maze Therapeutics, Inc.⁷
• Dec 29, 2025Sold 600 shares at $41.16 of Maze Therapeutics, Inc.⁷
• Dec 29, 2025Sold 9,400 shares at $40.54 of Maze Therapeutics, Inc.⁷
• Dec 29, 2025Exercised options 9,876 shares at $10.42 of Maze Therapeutics, Inc.⁷
• Dec 29, 2025Exercised options 124 shares at $10.42 of Maze Therapeutics, Inc.⁷